In today’s recent session, 0.95 million shares of the Vigil Neuroscience Inc (NASDAQ:VIGL) have been traded, and its beta is 1.85. Most recently the company’s share price was $2.64, and it changed around -$0.01 or -0.38% from the last close, which brings the market valuation of the company to $107.92M. VIGL at last check was trading at a discount to its 52-week high of $6.06, offering almost -129.55% off that amount. The share price’s 52-week low was $1.49, which indicates that the recent value has risen by an impressive 43.56% since then. We note from Vigil Neuroscience Inc’s average daily trading volume that its 10-day average is 0.43 million shares, with the 3-month average coming to 1.07 million.
Vigil Neuroscience Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.44. If we narrow it down even further, the data shows that 1 out of 9 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended VIGL as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Vigil Neuroscience Inc is expected to report earnings per share of -0.47 for the current quarter.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
Instantly VIGL has been showing red trend so far today with a performance of -0.38% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.88 on recent trading dayincreased the stock’s daily price by 8.33%. The company’s shares are currently up 55.29% year-to-date, but still down -3.30% over the last five days. On the other hand, Vigil Neuroscience Inc (NASDAQ:VIGL) is 51.72% up in the 30-day period. We can see from the shorts that 0.51 million shares have been sold at a short interest cover period of 5.31 day(s).
The consensus price target as assigned by Wall Street analysts is $11, which translates to bulls needing to increase their stock price by 76.0% from its current value. Analyst projections state that VIGL is forecast to be at a low of $11 and a high of $11.
Vigil Neuroscience Inc (VIGL) estimates and forecasts
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 21.27% of Vigil Neuroscience Inc shares, and 80.16% of them are in the hands of institutional investors. The stock currently has a share float of 101.81%. Vigil Neuroscience Inc stock is held by 77.0 institutions, with ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 14.6419% of the shares, which is about 5.84 million shares worth $23.35 million.
NORTHPOND VENTURES, LLC, with 10.5722% or 4.21 million shares worth $16.86 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and abrdn Life Sciences Investors were the top two Mutual Funds as of Sep 30, 2024. The former held 710.14 shares worth $1.89 million, making up 1.74% of all outstanding shares. On the other hand, abrdn Life Sciences Investors held roughly 235.01 shares worth around $0.63 million, which represents about 0.57% of the total shares outstanding.
